DKSH Hong Kong and Novartis Hong Kong Forge Partnership to Enhance Healthcare Solutions

Hong Kong, November 3, 2023 – DKSH’s Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, announces a partnership with Novartis Hong Kong, a global pharmaceutical company that delivers innovative medicines to alleviate society’s greatest disease burdens through technological leadership in research and development, and novel access approaches. This collaboration marks a significant step forward in advancing patient care and accessibility in the region.

Renowned for a full range of integrated services to support partners’ journey of growth, DKSH Hong Kong has been chosen by Novartis Hong Kong as one of its partners to implement the full agency business model in Hong Kong, delivering innovative healthcare solutions that prioritize the well-being and purpose of patients. With this partnership, DKSH manages a selected range of Novartis products in Hong Kong, encompassing sales, marketing, distribution, and other associated activities.

This partnership with Novartis grants DKSH Hong Kong access to a selection of portfolio of products in the market, covering oncology, immunology, and ophthalmology with over 20 innovative treatments. By leveraging DKSH's extensive distribution network and commercial expertise, the partnership aims to ensure that these life-changing treatments reach a significant number of patients, empowering them with improved options for their healthcare needs.

"We are thrilled to embark on this partnership with Novartis. This collaboration reflects DKSH's commitment to act with purpose and grow with passion, as we strive to provide better solutions for disease management and improve patient outcomes. By combining our expertise and resources with Novartis, we can offer an unparalleled level of healthcare services in Hong Kong," said Wai Ting Fong, Head of Management and Vice President, Healthcare, DKSH Hong Kong & Macau.

"We are excited to partner with DKSH in Hong Kong," stated Derek Chang, Head of Novartis Hong Kong. "This collaboration can enhance access to innovate medicines in both private and public sectors. By joining forces with DKSH, we can leverage their market expertise and expand our reach, ultimately providing more transformative treatments to more patients in Hong Kong."

Novartis Hong Kong partnership with DKSH Hong Kong Business Unit Healthcare not only reinforces DKSH's commitment to its purpose-driven approach but also strengthens its market position in the healthcare sector.